Divine Skin Inc., developer and formulator of personal care products, has added Dr. Keith Markey to its Board of Directors. Dr. Markey has been a research analyst for Griffin Securities for the past five years and has more than 25 years of experience in the financial services industry. His focus has been primarily on healthcare, biotech and medical device companies.
Divine Skin's CEO Daniel Khesin stated, "We are extremely pleased to have someone as experienced and knowledgeable as Dr. Markey joining our Board of Directors. We welcome Dr. Markey to the Divine Skin team."
Previously, Dr. Markey held various managerial positions in the Value Line Research Department. He began his career as a biochemist, working in the fields of endocrinology and neuroscience. His research, which resulted in more than 30 publications, contributed to the understanding of regulatory biochemistry and stem cell plasticity. He earned a Ph.D. in Neurochemistry from the University of Connecticut and an M.B.A. in Finance from the Leonard N. Stern School of Business at New York University.